Clinical Trials Logo

Febrile Seizures clinical trials

View clinical trials related to Febrile Seizures.

Filter by:
  • None
  • Page 1

NCT ID: NCT06444126 Recruiting - Clinical trials for Epilepsy in Children

The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures

Start date: March 15, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about the recurrence and development of epilepsy in children hospitalized with their first febrile seizures. The main questions it aims to answer are: - What is the risk of recurrence after the first febrile seizure and what are the risk factors for recurrent febrile seizures in Vietnamese children? - What is the risk of developing epilepsy later in life and what are the risk factors for developing epilepsy in Vietnamese children who have had febrile seizures?

NCT ID: NCT03631901 Completed - Febrile Seizures Clinical Trials

Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures

Start date: April 1, 2017
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy of oral melatonin compared to oral diazepam for prevention of recurrent simple febrile seizures.

NCT ID: NCT01884766 Completed - Epilepsy Clinical Trials

Copeptin in Childhood Epilepsy

EpiCop
Start date: April 2013
Phase: N/A
Study type: Observational

In many fields of medicine, except seizure disorders, blood biomarkers have captured an integrated part of diagnostic decision making, including copeptin, the surrogate marker of vasopressin release. There are strong arguments to hypothesize circulating copeptin is elevated in epilepsy, especially in generalized seizures such as fever seizures (FS), and that copeptin is predictive for complexity and relapse at least in FS. Although long-term morbidity and mortality are both low in FS, there is high anxiety among parents because of a lack of criterions to identify children at risk for relapse. Copeptin may fill this gap by adding important diagnostic and prognostic information. Eventually, less children may receive needlessly over years fever drugs or anti-epileptic drugs.